What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib.
Loehr A, Petrylak D, Watkins SP.
Front Oncol. 2022 Jun 20;12:951348. doi: 10.3389/fonc.2022.951348.